A Phase II Study of Intensity-Modulated Pleural Radiation Therapy (IMPRINT) in People with Thymic Cancer that Has Spread to the Lining of the Lungs and Chest


Full Title

Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) for Patients with Pleural Metastases from Thymic Malignancies


Intensity-modulated pleural radiation therapy (IMPRINT) is a type of radiation therapy that specifically targets the lining of the lungs and the inner side of the ribs to stop cancer from growing. In this study, researchers are studying the safety and effectiveness of IMPRINT to one side of the chest (hemithoracic IMPRINT) to treat people with thymic cancer (cancer of the thymus gland) that has spread to the lining of the lungs and chest.

Who Can Join

To be eligible for this study, patients must meet several requirements, including:

  • Participants must have thymic cancer that has spread to the lining of the lungs and chest.
  • Patients must be physically well enough that they are able to be mobile, take care of themselves, and engage in all but physically strenuous activities. For example, they must be well enough that they could carry out office work or light housework.
  • This study is for people age 18 and older.

For more information and to ask about eligibility for this study, please contact the office of Dr. Annemarie Shepherd at 908-542-3430.




Phase II (phase 2)

Disease Status

Newly Diagnosed


Andreas Rimner


ClinicalTrials.gov ID